$19.8 Billion is the total value of Polar Capital Holdings Plc's 286 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | DISC MEDICINE INCcall | $1,894,157,280 | – | 42,661,200 | +100.0% | 9.55% | – | |
MMYT | New | MAKEMYTRIP LIMITED MAURITIUScall | $1,593,182,490 | – | 59,050,500 | +100.0% | 8.04% | – |
MCK | New | MCKESSON CORP | $136,975,075 | – | 320,552 | +100.0% | 0.69% | – |
SNPS | New | SYNOPSYS INC | $134,422,823 | – | 308,727 | +100.0% | 0.68% | – |
RMBS | New | RAMBUS INC DEL | $84,005,781 | – | 1,309,113 | +100.0% | 0.42% | – |
FN | New | FABRINET | $73,479,090 | – | 565,746 | +100.0% | 0.37% | – |
New | INDIVIOR PLCord | $72,582,550 | – | 3,049,687 | +100.0% | 0.37% | – | |
MNDY | New | MONDAY COM LTD | $48,309,894 | – | 282,151 | +100.0% | 0.24% | – |
TDC | New | TERADATA CORP DEL | $48,084,970 | – | 900,299 | +100.0% | 0.24% | – |
BDX | New | BECTON DICKINSON & CO | $35,640,294 | – | 134,996 | +100.0% | 0.18% | – |
NBIX | New | NEUROCRINE BIOSCIENCES INC | $35,362,500 | – | 375,000 | +100.0% | 0.18% | – |
KRTX | New | KARUNA THERAPEUTICS INC | $32,841,933 | – | 151,450 | +100.0% | 0.17% | – |
BPMC | New | BLUEPRINT MEDICINES CORP | $31,600,000 | – | 500,000 | +100.0% | 0.16% | – |
ANSS | New | ANSYS INC | $22,853,363 | – | 69,196 | +100.0% | 0.12% | – |
DDOG | New | DATADOG INC | $22,751,851 | – | 231,265 | +100.0% | 0.12% | – |
New | ASCENDIS PHARMA A/Snote 2.250% 4/0 | $21,900,000 | – | 24,000,000 | +100.0% | 0.11% | – | |
ESTA | New | ESTABLISHMENT LABS HLDGS INC | $15,707,848 | – | 228,944 | +100.0% | 0.08% | – |
BKI | New | BLACK KNIGHT INC | $14,772,125 | – | 247,315 | +100.0% | 0.08% | – |
New | EXACT SCIENCES CORPnote 0.375% 3/1 | $12,952,500 | – | 12,000,000 | +100.0% | 0.06% | – | |
AXP | New | AMERICAN EXPRESS CO | $10,669,402 | – | 61,248 | +100.0% | 0.05% | – |
FROG | New | JFROG LTD | $10,534,670 | – | 380,313 | +100.0% | 0.05% | – |
XFOR | New | X4 PHARMACEUTICALS INCcall | $9,700,000 | – | 5,000,000 | +100.0% | 0.05% | – |
New | NATIONAL VISION HLDGS INCnote 2.500% 5/1 | $9,432,000 | – | 9,000,000 | +100.0% | 0.05% | – | |
CCEP | New | COCA-COLA EUROPACIFIC PARTNE | $8,141,310 | – | 126,359 | +100.0% | 0.04% | – |
DYN | New | DYNE THERAPEUTICS INC | $5,625,000 | – | 500,000 | +100.0% | 0.03% | – |
New | ETSY INCnote 0.125% 9/0 | $5,450,438 | – | 6,500,000 | +100.0% | 0.03% | – | |
New | BOOKING HOLDINGS INCnote 0.750% 5/0 | $5,263,300 | – | 3,500,000 | +100.0% | 0.03% | – | |
New | DATADOG INCnote 0.125% 6/1 | $4,984,000 | – | 4,000,000 | +100.0% | 0.02% | – | |
SQM | New | SOCIEDAD QUIMICA Y MINERA DEspon adr ser b | $4,429,820 | – | 61,000 | +100.0% | 0.02% | – |
New | LUMENTUM HLDGS INCnote 0.250% 3/1 | $4,248,000 | – | 4,000,000 | +100.0% | 0.02% | – | |
New | ATLASSIAN CORPORATIONcl a | $4,203,305 | – | 25,048 | +100.0% | 0.02% | – | |
AAPL | New | APPLE INCcall | $4,247,942 | – | 21,900 | +100.0% | 0.02% | – |
New | CINEMARK HLDGS INCnote 4.500% 8/1 | $3,423,500 | – | 2,500,000 | +100.0% | 0.02% | – | |
IMCR | New | IMMUNOCORE HLDGS PLCads | $2,538,467 | – | 42,336 | +100.0% | 0.01% | – |
GOOGL | New | ALPHABET INCcall | $2,633,400 | – | 22,000 | +100.0% | 0.01% | – |
EWBC | New | EAST WEST BANCORP INC | $1,562,373 | – | 29,596 | +100.0% | 0.01% | – |
PLL | New | PIEDMONT LITHIUM INC | $1,148,429 | – | 19,900 | +100.0% | 0.01% | – |
GH | New | GUARDANT HEALTH INC | $358,358 | – | 10,010 | +100.0% | 0.00% | – |
PDD | New | PDD HOLDINGS INCsponsored ads | $289,074 | – | 4,181 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-12-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MICROSOFT CORP | 12 | Q3 2023 | 5.8% |
APPLE INC | 12 | Q3 2023 | 4.7% |
ALPHABET INC | 12 | Q3 2023 | 3.3% |
NVIDIA CORPORATION | 12 | Q3 2023 | 5.4% |
ALPHABET INC | 12 | Q3 2023 | 3.0% |
ADVANCED MICRO DEVICES INC | 12 | Q3 2023 | 2.7% |
META PLATFORMS INC | 12 | Q3 2023 | 3.3% |
ARCH CAP GROUP LTD | 12 | Q3 2023 | 2.5% |
AMAZON COM INC | 12 | Q3 2023 | 2.3% |
CHUBB LIMITED | 12 | Q3 2023 | 1.9% |
View Polar Capital Holdings Plc's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Aeglea BioTherapeutics, Inc. | July 28, 2023 | 3,936,198 | 5.0% |
INFINITY PHARMACEUTICALS, INC. | February 14, 2023 | 2,071,242 | 2.3% |
Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
Summit Therapeutics Inc.Sold out | February 14, 2023 | 0 | 0.0% |
BELLUS Health Inc. | February 14, 2022 | 2,500,000 | 2.4% |
Oxford Immunotec Global PLCSold out | February 14, 2022 | 0 | 0.0% |
View Polar Capital Holdings Plc's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G | 2024-02-13 |
SC 13G | 2024-02-13 |
13F-HR/A | 2023-12-13 |
13F-HR/A | 2023-12-13 |
View Polar Capital Holdings Plc's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.